Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'c-Abl'

Search results for: 'c-Abl'

Items 61-70 of 72

Page
per page
  1. ZM 447439
    A4113 ZM 447439
    Target: Aurora Kinases|MEK|Src|Lck
    Summary: Aurora Kinase inhibitor,potent and selective
      ≥25.7 mg/mL
  2. I-BET-762
    B1498 I-BET-762
     4 Citation
    Target: Bromodomains
    Summary: BET inhibitor,highly potent
      ≥21.19 mg/mL
  3. Dabrafenib (GSK2118436)
    B1407 Dabrafenib (GSK2118436)
     3 Citation
    Target: Raf
    Summary: Inhibitor of BRAF(V600) mutants
      ≥26 mg/mL
  4. TAE226 (NVP-TAE226)
    A8557 TAE226 (NVP-TAE226)
     1 Citation
    Target: FAK
    Summary: FAK inhibitor,potent and ATP-competitive
      ≥23.45 mg/mL
  5. CP-673451
    B2173 CP-673451
    Target: PDGFR
    Summary: PDGFRα/β inhibitor,potent and selective
  6. Sorafenib
    A3009 Sorafenib
     2 Citation
    Target: Raf|VEGFR
    Summary: Raf kinases and tyrosine kinases inhibitor
      ≥23.25 mg/mL
  7. Danoprevir (RG7227)
    A4024 Danoprevir (RG7227)
    Target: HCV Proteases
    Summary: HCV NS3/4A protease inhibitor
      ≥32.6 mg/mL
  8. Vemurafenib (PLX4032, RG7204)
    A3004 Vemurafenib (PLX4032, RG7204)
     9 Citation
    Target: Raf
    Summary: BRAF kinase inhibitor
      ≥24.5 mg/mL
  9. Fluorouracil (Adrucil)
    A4071 Fluorouracil (Adrucil)
     3 Citation
    Target: Thymidylate Synthase
    Summary: Antitumor agent;inhibitor of thymidylate synthase
      insoluble in EtOH; ≥10.04 mg/mL
  10. Sunitinib malate
    A8255 Sunitinib malate
     2 Citation
    Target: VEGFR
    Summary: VEGFR/PDGFRβ/ KIT/ FLT3/RET/CSF-1R inhibitor
      ≥26.65 mg/mL

Items 61-70 of 72

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 68item
  2. Peptides 2item
  3. Peptides & Proteins 1 item
Reversibility
  1. Reversible 4item
  2. Irreversible 1 item
Target
  1. Proteasome 1 item
  2. Histone Deacetylases (HDACs) 1 item
  3. CXCR 1 item
  4. Raf 7item
  5. Aurora Kinases 4item
  6. mTOR 1 item
  7. Bromodomains 1 item
  8. AP-1 1 item
  9. MMP 1 item
  10. FLT3 5item
  11. Eph Receptors 2item
  12. VEGFR 14item
  13. PDGFR 11item
  14. c-Kit 6item
  15. RET 1 item
  16. Thymidylate Synthase 1 item
  17. Bcr-Abl 8item
  18. MEK 1 item
  19. FGFR 4item
  20. MET 5item
  21. Src 7item
  22. Trk Receptors 3item
  23. Microtubules/Tubulins 1 item
  24. EGFR 1 item
  25. FAK 1 item
  26. JAK 1 item
  27. DNA-PK 1 item
  28. AMPK 1 item
  29. Toll-like receptors (TLRs) 1 item
  30. c-MET 7item
  31. PKC 3item
  32. HCV Proteases 1 item
  33. Lyn 1 item
  34. HIV-1 gp120 1 item
  35. Tie-2 1 item
  36. Farnesyl Diphosphate Synthases 1 item
  37. Ron 1 item
  38. Synthases/Synthetases 1 item
  39. P110 1 item
  40. Hck 1 item
  41. ZAP-70 1 item
  42. c-Fms tyrosine kinase 1 item
  43. HCV polymerase 2item
  44. PC-PLC 1 item
  45. Lck 1 item
Reported Experiments
  1. Animal Experiments 63item
  2. Cell Experiments 44item
Related Disease
  1. Acute Myeloid Leukemia 3item
  2. Adrenocortical Carcinoma 1 item
  3. Autoimmune Diseases 1 item
  4. Bladder Cancer 2item
  5. Bladder Carcinoma 1 item
  6. Breast Cancer 10item
  7. Cancer 46item
  8. Cholangiocarcinoma 1 item
  9. Clear Cell Renal Cell Carcinoma 1 item
  10. Colon Cancer 7item
  11. Colon Carcinoma 2item
  12. Colorectal Cancer 7item
  13. Glioblastoma 4item
  14. Glioma 1 item
  15. HCV 2item
  16. Hepatitis C 1 item
  17. Hepatocellular Carcinoma 1 item
  18. HIV 1 item
  19. Leukemia 3item
  20. Liver Cancer 1 item
  21. Lung Cancer 7item
  22. Lung Carcinoma 2item
  23. Lymphoma 2item
  24. Melanoma 5item
  25. Multiple Myeloma 2item
  26. Non-small Cell Lung Cancer 2item
  27. Ovarian Cancer 4item
  28. Pancreatic Cancer 7item
  29. Prostate Cancer 3item
  30. Renal Cancer 1 item
  31. Renal Cell Carcinoma 4item
  32. Rheumatoid Arthritis 1 item
  33. Thyroid Cancer 4item